Figure 4
From: Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses
Inhibition of SARS-CoV-2 entry by TPNT1. (a) TPNT1 blocks binding of spike proteins to ACE2-Fc-Biotin; (b & c) TPNT1 inhibited syncytium formation between 293 T/Spike/EGFP and H1975-ACE2 cells. At least three independent experiments were performed and one representative result was shown. P < 0.001***.
